Ricevi le ultime notizie sulle azioni Legend Biotech con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di LEGN

Ultime notizie per

LEGEND BIOTECH CORP-ADR

Legend Biotech

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corporation - American Depositary Shares

Legend Biotech Corp

Press Releases

Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results

Earnings

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

News

Health Care

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

Management

Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

NanoViricides Reports NV-387's Anti-Inflammatory Effects Could Combat Viral-Induced Cancer Resurgence

LEGN

NNVC

REGN

VKTX

Abivax

Alkermes

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

BridgeBio Pharma

Caris Life Sciences

CRISPR Therapeutics

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Exact Sciences Corporation - Common Stock

Exact Sciences

Grifols, S.A. - American Depositary Shares

Grifols

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals

Krystal Biotech

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Jyong Biotech

Moderna

Merus

Metsera

Nuvalent

Vaxcyte

PTC Therapeutics

Avidity Biosciences

Roivant Sciences

Revolution Medicines, Inc. - Common Stock

Revolution Medicines

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

TG Therapeutics

Cantor Fitzgerald

JP Morgan

RBC Capital

Morgan Stanley

HC Wainwright & Co.

Comments

Legend Biotech Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO